Lindbrook Capital, LLC Clovis Oncology, Inc. Transaction History

Lindbrook Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$4.06 - $5.8 $913 - $1,305	-225 Closed	0 $0
Q2 2021 Jul 27, 2021	SELL	$5.02 - $7.05 $4,593 - $6,450	-915 Reduced 80.26%	225 $1,000
Q4 2020 Jan 27, 2021	BUY	$4.13 - $6.41 $3,993 - $6,198	967 Added 558.96%	1,140 $5,000
Q3 2020 Nov 03, 2020	SELL	$4.82 - $7.72 $1,995 - $3,196	-414 Reduced 70.53%	173 $1,000
Q2 2020 Jul 27, 2020	BUY	$5.69 - $9.69 $3,340 - $5,688	587 New	587 $4,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.